The University of Southampton
University of Southampton Institutional Repository

Genetic profiling of haematological malignancies

Genetic profiling of haematological malignancies
Genetic profiling of haematological malignancies

Acute lymphoblastic leukaemia (ALL) accounts for approximately 3% of all cancers, and leads to more than 4250 deaths a year. The different classes of leukaemia comprise numerous heterogeneous subgroups, which differ in their cellular and molecular characteristics, as well as their response to therapy. Accurate risk stratification is essential for tailoring of therapy, and achieving optimal outcome in contemporary treatment regimes. Based upon clinical features and cytogenetic and molecular diagnostics, the majority of ALL patients are assigned to one of the following prognostically significant subtypes having; ETV6-RUNX1, BCR-ABL1 or TCF3-PBX1 fusions, MLL rearrangements, high hyperdiploidy (HeH) with >50 chromosomes, hypodiploidy or T-ALL. Whilst in leukaemogenesis, and provide diagnostic and prognostic markers, co-operating oncogenic aberrations are often required for the production of a full leukaemic phenotype. A number of additional aberrations have been identified within some cytogenetic subgroups, but the full complement of cooperating abnormalities, and their distribution within ALL subtypes remains to be defined. these genetic abnormalities are important In this study the genomic changes in a total of 94 ALL patients from the ETV6-RUNX1 (n=34), iAMP21 (n=19) and unclassified (n=41) patient subgroups were characterised using cytogenetics, FISH, array comparative genomic hybridisation, molecular copy number counting, mutation analysis, qRT-PCR and targeted gene expression arrays. This approach allowed the identification of a range of large scale and submicroscopic aberrations, targeting multiple known and novel regions, including a number of genes. The elucidation of pathways and genes dysregulated in these malignant subgroups has provided further insight into the underlying cause of the disease phenotype. The PDE9A and TBL1XR1 genes were implicated in the pathogenesis of iAMP21 and ETV6-RUNX1 patients, respectively. Additionally, the potential prognostic significance of the ADD3 gene in ETV6-RUNX1 positive ALL was revealed.

University of Southampton
Parker, Helen
18f3acd9-39b7-4df6-99e4-68b400427798
Parker, Helen
18f3acd9-39b7-4df6-99e4-68b400427798

Parker, Helen (2008) Genetic profiling of haematological malignancies. University of Southampton, Doctoral Thesis.

Record type: Thesis (Doctoral)

Abstract

Acute lymphoblastic leukaemia (ALL) accounts for approximately 3% of all cancers, and leads to more than 4250 deaths a year. The different classes of leukaemia comprise numerous heterogeneous subgroups, which differ in their cellular and molecular characteristics, as well as their response to therapy. Accurate risk stratification is essential for tailoring of therapy, and achieving optimal outcome in contemporary treatment regimes. Based upon clinical features and cytogenetic and molecular diagnostics, the majority of ALL patients are assigned to one of the following prognostically significant subtypes having; ETV6-RUNX1, BCR-ABL1 or TCF3-PBX1 fusions, MLL rearrangements, high hyperdiploidy (HeH) with >50 chromosomes, hypodiploidy or T-ALL. Whilst in leukaemogenesis, and provide diagnostic and prognostic markers, co-operating oncogenic aberrations are often required for the production of a full leukaemic phenotype. A number of additional aberrations have been identified within some cytogenetic subgroups, but the full complement of cooperating abnormalities, and their distribution within ALL subtypes remains to be defined. these genetic abnormalities are important In this study the genomic changes in a total of 94 ALL patients from the ETV6-RUNX1 (n=34), iAMP21 (n=19) and unclassified (n=41) patient subgroups were characterised using cytogenetics, FISH, array comparative genomic hybridisation, molecular copy number counting, mutation analysis, qRT-PCR and targeted gene expression arrays. This approach allowed the identification of a range of large scale and submicroscopic aberrations, targeting multiple known and novel regions, including a number of genes. The elucidation of pathways and genes dysregulated in these malignant subgroups has provided further insight into the underlying cause of the disease phenotype. The PDE9A and TBL1XR1 genes were implicated in the pathogenesis of iAMP21 and ETV6-RUNX1 patients, respectively. Additionally, the potential prognostic significance of the ADD3 gene in ETV6-RUNX1 positive ALL was revealed.

Text
1226624.pdf - Version of Record
Available under License University of Southampton Thesis Licence.
Download (40MB)

More information

Published date: 2008

Identifiers

Local EPrints ID: 466590
URI: http://eprints.soton.ac.uk/id/eprint/466590
PURE UUID: 4463fdfd-abfb-4e38-b6d1-d4690396cdbd

Catalogue record

Date deposited: 05 Jul 2022 05:55
Last modified: 16 Mar 2024 20:48

Export record

Contributors

Author: Helen Parker

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×